中文别名:
2,3',4,6-四氯联苯;N-甲酰基-O-(4-羟基-3,5-二碘苯基)-3,5-二碘-1-酪氨酸;Α-羟基四碘甲状腺乙酸;
英文别名:
hydroxy-[4-(4-hydroxy-3,5-diiodo-phenoxy)]-3,5-diiodophenylacetic acid;3,5,3´,5´-Tetraiodo Thyromandelic Acid;2-hydroxy-2-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]acetic acid;3,5,3',5'-Tetraiodo Thyromandelic Acid;4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodomandelic Acid;A-Hydroxy-4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzeneacetic Acid;3,5,3',5'-Tetraiodo Thyromandelic Acid (>85%);2-Hydroxy-2-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid;2-Hydroxy-2-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid, (+/-)-;UNII-701CVV6PLQ;AKOS030254768;BENZENEACETIC ACID, .ALPHA.-HYDROXY-4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODO-;T4-hydroxyacetic acid;Benzeneacetic acid, alpha-hydroxy-4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-;Q27265806;LEVOTHYROXINE SODIUM IMPURITY, T4-HYDROXYACETIC ACID- [USP IMPURITY];93647-48-4;HYDROXY-[4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL]-ACETIC ACID;Levothyroxine sodium impurity, T4-hydroxyacetic acid- [USP];701CVV6PLQ;FT-0675073;
Inchi:
1S/C14H8I4O5/c15-7-3-6(4-8(16)12(7)20)23-13-9(17)1-5(2-10(13)18)11(19)14(21)22/h1-4,11,19-20H,(H,21,22)